Life sciences companies are quickly integrating artificial intelligence into their work, but guardrails for using the ...

A cell therapy developer with operations at the Philadelphia Navy Yard plans reduce its headcount by 33% next year as it ...

The campaign we have all just gone through has not been very focused on a lot of policy detail," said Buchanan Ingersoll & ...

Vance Street, based in Los Angeles, is a middle market private equity firm that invests in several sectors, including medical technology and life science. The firm typically pursues companies with ...

The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...

Dr. Verena Kallhoff serves as Sr. Director, Global Life Sciences at the Greater Houston Partnership. She works together with ...

The U.S. life sciences development bubble burst at the start of 2024, and it is going to take some time simply to pick up the pieces. There are already signs of recovery for the new year, though.

In a report released yesterday, Madison Elsaadi from B.Riley Financial reiterated a Buy rating on Wave Life Sciences (WVE – Research ...

Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...

TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...

What is your favorite part about practicing life sciences law at McDermott? Clients come to us with difficult questions that require not just ...

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies ...